期刊文献+

唑来膦酸注射液致不良反应1例 被引量:3

One case of adverse reaction caused by zoledronic acid injection
暂未订购
导出
摘要 1例74a女性患者,因严重骨质疏松首次给予唑来膦酸注射液5mg静脉滴注。用药第2天,患者出现头晕、头痛、胸痛、全身关节疼痛加重,BP160/80mmHg,T38.4℃。给予硝酸甘油、吸氧、吲哚美辛、塞来昔布、眩晕宁等对症治疗,14d后患者症状好转。 A 74-year-old woman with severe osteoporosis received an intravenous infusion of zoledronic acid injection 5 mg.On day 2,the patient developed dizziness,headache,chest pain and aggravation of arthralgia.Her temperature was 38.4 ℃,and the blood pressure was 160/80 mmHg.The therapy of oxygen inhalation,nitroglycerin,indomethacin,celecoxib and Xuanyunning was given for symptomatic treatment.Fourteen days later,her symptoms improved.
作者 时慧 纪立伟
出处 《中国药物应用与监测》 CAS 2010年第6期382-383,共2页 Chinese Journal of Drug Application and Monitoring
关键词 唑来膦酸注射液 药品不良反应 Zoledronic acid injection Adverse drug reaction
  • 相关文献

参考文献4

二级参考文献40

  • 1张文武 主编.急诊内科学[M].北京:人民卫生出版社,2001.507-575.
  • 2Evdokiou A,Labrinidis A.Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis[J].Bone,2003,33(2):216.
  • 3Neville-Webbe H,Coleman R E.The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia[J].Palliat Med,2003,17(6):539.
  • 4Witters L M,Crispino J.Effect of the Combination of Docetaxel,Zoledronic Acid,and a COX-2 Inhibitor on the Growth of Human Breast Cancer Cell Lines[J].Am J Clin Oncol,2003,26(4):S92.
  • 5Jagdev S P,Croucher P I,Coleman R E.Zoledronate induces apoptosis of breast cancer cells in vitro-Evidence for additive and synergistic effects with taxol and tamoxifen[J].Proc Am Soc Clin Oncol,2000,19:664a.
  • 6Tassone P,Forciniti S,Galea E,et al.Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines[J].Leukemia,2000,14:841.
  • 7Chen T,Berenson J.Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases[J].J Clin Pharmacol,2002,42(11):1228.
  • 8Skerjanec A,Berenson J.The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function[J].J Clin Pharmacol,2003,43(2):154.
  • 9Lipton A,Zheng M,Seaman J,et al.Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma[J].Cancer,2003,98(5):962.
  • 10Smith M R,Eastham J,Gleason D M.Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer[J].J Urol,2003,169(6):2008.

共引文献59

同被引文献36

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部